Legacy Education Inc. (LGCY) Q2 2025 Earnings Call Transcript — Neutral
LGCY Seeking Alpha — February 13, 2025Legacy Education Inc. (NYSE:LGCY ) Q2 2025 Earnings Conference Call February 13, 2024 4:30 PM ET Company Participants Nicole Joseph - SVP, Marketing LeeAnn Rohmann - CEO & Founder Matt Berry - SVP, Financial Planning and Analysis Conference Call Participants Jeff Cohen - Ladenburg Thalmann Mike Grondahl - Northland Securities Operator Good day and welcome to the Legacy Education, Inc. Second Quarter Fiscal 2025 Earnings Conference Call. Today's call is being recorded and broadcast live.

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MODV — Neutral
MODV GlobeNewsWire — February 13, 2025NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., February 13, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ModivCare Inc. (NASDAQ: MODV) between November 3, 2022 and September 15, 2024, both dates inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline.

Ultragenyx Pharmaceutical Inc. (RARE) Q4 2024 Earnings Call Transcript — Neutral
RARE Seeking Alpha — February 13, 2025Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Joshua Higa - VP, IR Emil Kakkis - CEO and President Erik Harris - CCO Howard Horn - CFO Eric Crombez - CMO Conference Call Participants Tazeen Ahmad - Bank of America Salveen Richter - Goldman Sachs Gena Wang - Barclays Yaron Werber - TD Cowen Joon Lee - Truist Securities Jeff Hung - Morgan Stanley Rick Miller - Cantor Fitzgerald Luca Issi - RBC Capital Liisa Bayko - Evercore ISI Operator Good afternoon, and welcome to the Ultragenyx Fourth Quarter and …

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – PSNY — Neutral
PSNY GlobeNewsWire — February 13, 2025NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Polestar Automotive Holding UK PLC (NASDAQ: PSNY) between November 14, 2022 and January 16, 2025, both dates inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

DBGI Announces Pricing of $7.5 Million Public Offering of Units of Common Stock and/or Pre-Funded Warrants and Warrants — Neutral
DBGI GlobeNewsWire — February 13, 2025Austin, TX, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (“DBG”) (OTC PINK: DBGI), a curated collection of luxury lifestyle brands, announces the pricing of its public offering of an aggregate of 11.36 million units, of which each unit includes a share of common stock and/or pre-funded warrant to purchase common stock, plus two common stock purchase warrants, at a public offering price of $0.66 per unit (minus $0.0001 per unit that includes a pre-funded warrant). The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be $7.5 million. …

Berkshire Hathaway's cash pile has surged to a record of over $320 billion, driven by stock sales, notably AAPL, and limited significant new investments. Cash is not as high when measured against the size of the balance sheet, standing at a similar level as in 2005, when cash rates were also at a peak. Cash continues to accumulate while its own valuation remains robust, raising questions about future capital allocation and even of potential dividends.

InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants — Neutral
IFRX GlobeNewsWire — February 13, 2025JENA, Germany, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today the pricing of its underwritten public offering of 8,250,000 ordinary shares of the Company at an offering price of $2.00 per ordinary share and in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 6,750,000 of the Company's ordinary shares. The purchase price of each pre-funded warrant is equal to the price per share at which ordinary shares are being sold to the public in this offering, minus $0.001, which …

Bright Horizons Family Solutions Inc. (BFAM) Q4 2024 Earnings Call Transcript — Neutral
BFAM Seeking Alpha — February 13, 2025Bright Horizons Family Solutions Inc. (NYSE:BFAM ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Michael Flanagan - Vice President of Investor Relations Stephen Kramer - Chief Executive Officer Elizabeth Boland - Chief Financial Officer Conference Call Participants Manav Patnaik - Barclays Bank George Tong - Goldman Sachs Andrew Steinerman - JPMorgan Chase & Co. Jeffrey Meuler - Robert W. Baird & Co. Joshua Chan - UBS Toni Kaplan - Morgan Stanley Jeffrey Silber - BMO Capital Markets Faiza Alwy - Deutsche Bank AG Operator Greetings, and welcome to Bright Horizons Family Solutions Fourth Quarter …

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK Lawsuit – GSK — Neutral
GSK Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129438&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on Grocery Outlet Holding Corp.(GO) should contact Levi & Korsinsky about pending Class Action - GO — Neutral
GO Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=129439&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Elastic N.V. Lawsuit – ESTC — Neutral
ESTC Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=129440&wire=1 or contact Joseph E.

Edison International Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – EIX — Neutral
EIX Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129437&wire=1 or contact Joseph E. Levi, Esq.

Air Lease Corporation (AL) Q4 2024 Earnings Call Transcript — Neutral
AL Seeking Alpha — February 13, 2025Air Lease Corporation (NYSE:AL ) Q4 2024 Earnings Conference Call February 13, 2024 4:30 PM ET Company Participants Jason Arnold - Head, IR Steven Hazy - Executive Chairman John Plueger - CEO and President Gregory Willis - EVP and CFO Conference Call Participants Catherine O'Brien - Goldman Sachs Terry Ma - Barclays Jamie Baker - JPMorgan Moshe Orenbuch - TD Cowen Hillary Cacanando - Deutsche Bank Stephen Trent - Citi Ron Epstein - Bank of America Operator Good afternoon, my name is Christa and I will be your conference operator today. At this time, I would like to welcome everyone …

AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript — Neutral
RCEL Seeking Alpha — February 13, 2025AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Matthew Park - Cantor Fitzgerald Ryan Zimmerman - BTIG Brooks O'Neil - Lake Street Capital Markets Joshua Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2024 Earnings Conference Call.

DexCom, Inc. (DXCM) Q4 2024 Earnings Call Transcript — Neutral
DXCM Seeking Alpha — February 13, 2025DexCom, Inc. (NASDAQ:DXCM ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Sean Christensen - Vice President of Finance and Investor Relations Kevin Sayer - Chairman, President and Chief Executive Officer Jereme Sylvain - Chief Financial Officer Jake Leach - Chief Operating Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jeff Johnson - Baird Robbie Marcus - J.P. Morgan Danielle Antalffy - UBS Travis Steed - Bank of America Joanne Wuensch - Citibank Matt Taylor - Jefferies Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Capital Markets Chris …

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WBA — Neutral
WBA Accesswire — February 13, 2025NEW YORK, NY / ACCESS Newswire / February 13, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Walgreens common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Warrior Met Coal, Inc. (HCC) Q4 2024 Earnings Call Transcript — Neutral
HCC Seeking Alpha — February 13, 2025Warrior Met Coal, Inc. (NYSE:HCC ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Corporate Participants D'Andre Wright - Vice President of External Affairs and Communications Walter Scheller - Chief Executive Officer Dale Boyles - Chief Financial Officer Conference Call Participants Nick Giles - B. Riley Katja Jancic - BMO Capital Markets Nathan Martin - The Benchmark Company Operator Good afternoon.

Don't Forget Value As Robinhood Benefits From Speculation Trends — Neutral
HOOD Seeking Alpha — February 13, 2025Robinhood Q4 was strong, but lofty growth targets risk overshooting reality; the speculative user base and tokenization pivot raise questions about a lasting moat. A crypto-centric focus and budding prediction markets may amplify speculation, limiting appeal among serious capital managers and threatening long-term stability. Despite fair valuation and moderate upside, near-term profitability hurdles and volatility suggest a Hold stance targeting ~10% annual returns.

Digital Realty Trust, Inc. (DLR) Q4 2024 Earnings Call Transcript — Neutral
DLR Seeking Alpha — February 13, 2025Digital Realty Trust, Inc. (NYSE:DLR ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Jordan Sadler - SVP of Public and Private IR Andy Power - President and CEO Matt Mercier - CFO Chris Sharp - CTO Greg Wright - CIO Colin McLean - CRO Conference Call Participants David Barden - Bank of America Richard Choe - JPMorgan Irvin Liu - Evercore ISI Jonathan Atkin - RBC Michael Rollins - Citi Matt Niknam - Deutsche Bank Ari Klein - BMO David Guarino - Green Street Frank Louthan - Raymond James Jim Schneider - Goldman Sachs …

The AZEK Company: Outperforming The Market With Strong Residential Growth — Positive
AZEK Seeking Alpha — February 13, 2025The AZEK Company achieved 18.7% YoY topline growth in Q1 FY25, driven by a 22% increase in the Residential segment, despite commercial segment challenges. Continued healthy demand along with new product launches and expanded reach via distribution partnerships are expected to sustain topline growth in FY25. Benefit from strong residential sales and a focus on cost savings and efficiency improvement, expected to drive margin growth in the quarters ahead.
